Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

ADIR discovers new compounds with affinity for imidazoline receptors

Aug. 12, 1998

Searle withdraws support for development of CCD-3693; CoCensys will forge ahead

Aug. 11, 1998

Studies with spheron-targeted AD treatment candidate yield promising results

Aug. 11, 1998

MABE: a new enkephalin analogue with analgesic potential

Aug. 11, 1998

New CNS agents described by French team

Aug. 11, 1998

4030W92 antihyperalgesic effect due to preferential action on slow activation state of Na+ channel

Aug. 11, 1998

Japanese investigators study antinociceptive dynorphin analogue

Aug. 10, 1998

Promising new antipsychotic agent in active development at Gedeon Richter

Aug. 10, 1998

Exelon demonstrates robust effects on cognitive function in Alzheimer's disease patients

Aug. 10, 1998

Clinical trials to begin shortly with KT-7515/CEP-1347

July 31, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...